CliniGA CRO

CliniGA CRO Blog

Negative Results: Keeping Publication Work Independent of the Expected Effect

Plan publication work independently of result direction and report negative findings with their uncertainty and limitations.

Representative research photograph: Negative Results: Keeping Publication Work Independent of the Expected Effect
Photo: Maggie Bartlett, employee of National Human Genome Research Institute · License: Public domain · Cropped and resized.
Published
Updated

Publication coordination may slow when a study does not support the hoped-for effect. Planning resources and ownership only around positive findings can leave the knowledge from completed research invisible and weaken the value of the study.

The publication decision

Define ownership, data preparation and publication decisions independently of result direction. Negative, inconclusive and insufficiently informative findings are not interchangeable labels. Describe the study question, uncertainty and limitations appropriately. WHO’s transparency work is a relevant reference for addressing selective visibility based on whether findings appear favourable to the sponsor or investigator.

Worked example

For example, a trial misses its principal objective and the team shifts attention to more attractive subgroup findings. The coordinator tracks reporting of the original question, while statisticians and authors consider the main result, exploratory findings and limitations together. The project does not remain indefinitely paused until a positive narrative can be found.

Coordination checks

  • Assign publication ownership and resources independently of result direction.
  • Review the balance between principal results and exploratory findings.
  • Track reasons for delay and other relevant routes for public disclosure.

Acceptance and boundaries

Acceptance means the actual question and findings have a complete, balanced reporting route. This operational recommendation does not impose one legal deadline across jurisdictions; assess applicable reporting duties separately. Journal rejection does not mean that no public disclosure is possible. Consider other suitable publication or results-reporting routes within their relevant conditions.

Frequently asked questions

Does statistical nonsignificance mean there is no effect?
Not by itself; assess the estimate, uncertainty and design limitations with appropriate expertise.
Does rejection mean the study remains undisclosed?
Other appropriate disclosure routes and applicable results-reporting responsibilities still need consideration.

Sources

  1. WHO — Joint statement on public disclosure of clinical trial results
  2. ICMJE — Preparing a manuscript for submission to a medical journal